Sickle Cell Disease Trial, Recruiting (NCT05210114)

Sickle Cell Disease Trial, Recruiting NCT05210114 Sponsor: Enrico Novelli Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05210114 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Sickle Cell Disease (specific types include SS, SC, Sß-thalassemia, SD, or SOArab)
People who are 12 years old or older
People who have given their legal consent to take part in all parts of the study

Who may not be able to join:

People who are under 12 years old
People who are currently taking part in another clinical trial involving an experimental treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enrico Novelli, MD, University of Pittsburgh

Phone: 412-916-3416

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05210114

Sponsor: Enrico Novelli

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 412-916-3416

More information: https://clinicaltrials.gov/study/NCT05210114

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Sickle Cell Disease (specific types include SS, SC, Sß-thalassemia, SD, or SOArab)
People who are 12 years old or older
People who have given their legal consent to take part in all parts of the study

Who may not be able to join:

People who are under 12 years old
People who are currently taking part in another clinical trial involving an experimental treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Enrico Novelli

Registry

ClinicalTrials.gov

Start date

21 January 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Dermal water content measurements in SCD participants at baseline state of health; Dermal water content measurements before fluid resuscitation in SCD participants with VOC or VOE; Dermal water content measurements after fluid resuscitation in SCD participants with VOC or VOE; Clinical dehydration assessments in SCD participants; Measurement of serum osmolality as a laboratory biomarker of dehydration in SCD participants; Measurement of hyperadhesion as a laboratory biomarker of dehydration in SCD participants; Measurement of elongation index as a cellular biomarker of dehydration in SCD parti...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov